68ga-dotatate
Showing 1 - 5 of 5
Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)
Completed
- Neuroendocrine Carcinoma
- 68Ga-DOTATATE
-
Los Angeles, CaliforniaUniversity of California Los Angeles, Nuclear Medicine Clinic of
May 12, 2021
Hyperparathyroidism, Hypercalcemia, Parathyroid Tumor Trial run by the NIDDK (68Ga-Dotatate, 18F-DOPA)
Completed
- Hyperparathyroidism
- +4 more
- 68Ga-Dotatate
- 18F-DOPA
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 12, 2022
Tumor-Induced Osteomalacia Trial in Beijing (68Ga-Dotatate, 68Ga-DOTA-JR11)
Recruiting
- Tumor-Induced Osteomalacia
- 68Ga-Dotatate
- 68Ga-DOTA-JR11
-
Beijing, Dongcheng, ChinaPeking union medical college hospital
Jan 2, 2021
Neuroendocrine Tumors Trial in Beijing (68Ga-DOTATATE)
Unknown status
- Neuroendocrine Tumors
- 68Ga-DOTATATE
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Jul 30, 2019
Oncogenic Osteomalacia, Mesenchymal Tumor Trial in Beijing (68Ga-DOTATATE)
Unknown status
- Oncogenic Osteomalacia
- Mesenchymal Tumor
- 68Ga-DOTATATE
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Apr 5, 2017